Risk Factors for Bleeding and Clinical Ineffectiveness Associated With Clopidogrel Therapy: A Comprehensive Meta‐Analysis
Although clopidogrel is a frequently used antiplatelet medication to treat and prevent atherothrombotic disease, clinicians must balance its clinical effectiveness with the potential side effect of bleeding. However, many previous studies have evaluated beneficial and adverse factors separately. The...
Main Authors: | Khoa A. Nguyen, Michael T. Eadon, Ryan Yoo, Evan Milway, Allison Kenneally, Kevin Fekete, Hyun Oh, Khanh Duong, Elizabeth C. Whipple, Titus K. Schleyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.12926 |
Similar Items
-
Puncture site bleeding complications in patients with Clopidogrel hyper-response
by: Nedeljković Žarko, et al.
Published: (2020-03-01) -
Evaluation of serious bleeding signals during concomitant use of clopidogrel and hypnotic drugs
by: Thanh Phuong Pham Nguyen, et al.
Published: (2021-07-01) -
Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel
by: Gwang-Un Kim, et al.
Published: (2021-01-01) -
Thoracentesis under clopidogrel is not associated with excessive bleeding events: a cohort study
by: Sivan Perl, et al.
Published: (2020-10-01) -
Postoperative Bleeding Risk for Oral Surgery under Continued Clopidogrel Antiplatelet Therapy
by: Alexander Gröbe, et al.
Published: (2015-01-01)